Histone Acetyltransferase Activity of p300 Is Required for the Promotion of Left Ventricular Remodeling After Myocardial Infarction in Adult Mice In Vivo

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Circulation

• Publication date

  2006-02-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.105.585182PMID 16461841
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Transcriptional Coactivator p300 Plays a Critical Role in the Hypertrophic and Protective Pathways Induced by Phenylephrine in Cardiac Cells but Is Specific to the Hypertrophic Effect of Urocortin

  2005cited by this paper
• Distinct serine residues in CBP and p300 are necessary for their activation by phenylephrine.

  2004cited by this paper
• Endothelin-1–Dependent Nuclear Factor of Activated T Lymphocyte Signaling Associates With Transcriptional Coactivator p300 in the Activation of the B Cell Leukemia-2 Promoter in Cardiac Myocytes

  2004cited by this paper
• Protein Kinases C and D Mediate Agonist-Dependent Cardiac Hypertrophy through Nuclear Export of Histone Deacetylase 5

  2004cited by this paper
• Cardiac p300 Is Involved in Myocyte Growth with Decompensated Heart Failure

  2003cited by this paper
• Left ventricular pressure-volume relationship in a murine model of congestive heart failure due to acute viral myocarditis.

  2002cited by this paper
• Heterogeneity in the Management and Outcomes of Patients With Acute Myocardial Infarction Complicated by Heart Failure: The National Registry of Myocardial Infarction

  2002cited by this paper
• p300/CBP proteins: HATs for transcriptional bridges and scaffolds.

  2001cited by this paper
• Molecular Regulation of the Endothelin-1 Gene by Hypoxia

  2001cited by this paper
• The Transcription Factors GATA4 and GATA6 Regulate Cardiomyocyte Hypertrophy in Vitro and in Vivo *

  2001cited by this paper
• Functional analysis of the p300 acetyltransferase domain: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity.

  2001cited by this paper
• Control of Cardiac-specific Transcription by p300 through Myocyte Enhancer Factor-2D*

  2001cited by this paper
• p300 Protein as a Coactivator of GATA-5 in the Transcription of Cardiac-restricted Atrial Natriuretic Factor Gene*

  1999cited by this paper
• MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium.

  1999cited by this paper
• Phosphorylation by p44 MAP Kinase/ERK1 stimulates CBP histone acetyl transferase activity in vitro.

  1999cited by this paper
• Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats.

  1998cited by this paper
• The cellular and molecular response of cardiac myocytes to mechanical stress.

  1997cited by this paper
• Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

  1997cited by this paper
• Acetylation of general transcription factors by histone acetyltransferases.

  1997cited by this paper
• Binding and modulation of p53 by p300/CBP coactivators

  1997cited by this paper
• cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction.

  1997cited by this paper
• Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload.

  1997cited by this paper
• Serum Response Factor Mediates AP-1-dependent Induction of the Skeletal -Actin Promoter in Ventricular Myocytes (*)

  1996cited by this paper
• The transcriptional coactivators p300 and CBP are histone acetyltransferases.

  1996cited by this paper
• The GATA-4 transcription factor transactivates the cardiac muscle-specific troponin C promoter-enhancer in nonmuscle cells

  1994cited by this paper
• Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.

  1994cited by this paper
• Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart

  1993cited by this paper
• Transcriptional regulation during cardiac growth and development.

  1993cited by this paper
• A direct link between core histone acetylation and transcriptionally active chromatin.

  1988cited by this paper
• Compensatory hypertrophy in the heart after myocardial infarction in the rat.

  1983cited by this paper

• Current opinion in cardiology, epigenetics of heart failure.

  2026cites this paper
• Cardiac epigenome in heart development and disease.

  2026cites this paper
• Unraveling the metabolic‒epigenetic nexus: a new frontier in cardiovascular disease treatment

  2025cites this paper
• Nobiletin Prevents Cardiac Hypertrophy via SIRT5-Mediated Downregulation of p300.

  2025cites this paper
• Role of Perturbations of Epigenetic Processes in Cardiac Hypertrophy and Fibrotic Scarring.

  2025cites this paper
• Cardiac-specific overexpression of PRMT5 exacerbates pressure overload-induced hypertrophy and heart failure

  2025cites this paper
• CNP inhibits T3 - induced hypertrophic growth in H9c2 cells: Impact of HDAC inhibitor.

  2025cites this paper
• Integrating Traditional Chinese Medicine and Modern Pharmacology: The Role of (Curcumin) in Cardiovascular Health

  2025cites this paper
• YAP K236 Acetylation Facilitates its Nucleic Export and Deprived the Protection against Cardiac Hypertrophy in Mice.

  2024cites this paper
• Role of transcriptional cofactors in cardiovascular diseases.

  2024cites this paper
• Inhibition of Hsp90 K284 Acetylation Aalleviates Cardiac Injury After Ischemia–Reperfusion Injury

  2024cites this paper
• Microtubules Sequester Acetylated YAP in the Cytoplasm and Inhibit Heart Regeneration

  2024cites this paper
• Nanotechnology-based drug delivery systems for curcumin and its derivatives in the treatment of cardiovascular diseases

  2024cites this paper
• 6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure

  2023cites this paper
• Roles of histone acetylation sites in cardiac hypertrophy and heart failure

  2023cites this paper
• Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

  2023cites this paper
• The protective role of EP300 in monocrotaline-induced pulmonary hypertension

  2023cites this paper
• Molecular perspectives in hypertrophic heart disease: An epigenetic approach from chromatin modification

  2022cites this paper
• The Polyunsaturated Fatty Acids, EPA and DHA, Ameliorate Myocardial Infarction-induced Heart Failure by Inhibiting p300-HAT Activity in Rats.

  2022cites this paper
• Multimerization of the GATA4 transcription factor regulates transcriptional activity and cardiomyocyte hypertrophic response

  2022cites this paper
• Acetyltransferase p300 regulates atrial fibroblast senescence and age‐related atrial fibrosis through p53/Smad3 axis

  2022cites this paper
• Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex

  2022cites this paper
• Metabolic substrates, histone modifications, and heart failure.

  2022cites this paper
• Effects of high-absorption curcumin for the prevention of hypertensive heart disease: a double-blind, placebo-controlled, randomized clinical study

  2022cites this paper
• Coronary artery disease and cancer: a significant resemblance

  2022cites this paper
• Ecklonia stolonifera Okamura Extract Suppresses Myocardial Infarction-Induced Left Ventricular Systolic Dysfunction by Inhibiting p300-HAT Activity

  2022cites this paper
• Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors

  2022cites this paper
• Studying Epigenetics of Cardiovascular Diseases on Chip Guide

  2022cites this paper
• Toward a New Paradigm for Targeted Natriuretic Peptide Enhancement in Heart Failure

  2021cites this paper
• Curcumin, an Inhibitor of p300-HAT Activity, Suppresses the Development of Hypertension-Induced Left Ventricular Hypertrophy with Preserved Ejection Fraction in Dahl Rats

  2021cites this paper
• Multimerization of the GATA 4 transcription factor regulates transcriptional 1 activity and cardiomyocyte hypertrophic response 2 3

  2021cites this paper
• Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.

  2021cites this paper
• Function of histone methylation and acetylation modifiers in cardiac hypertrophy.

  2021cites this paper
• Scope to develop sirtuins modulators as a therapy to attenuate cardiac complications

  2021cites this paper
• Fetal Gene Reactivation in Pulmonary Arterial Hypertension: GOOD, BAD, or BOTH?

  2021cites this paper
• Acetyltransferase p300 Is a Putative Epidrug Target for Amelioration of Cellular Aging-Related Cardiovascular Disease

  2021cites this paper
• Histone Acetylation Domains Are Differentially Induced during Development of Heart Failure in Dahl Salt-Sensitive Rats

  2021cites this paper
• BRG1 Stimulates Endothelial Derived Alarmin MRP8 to Promote Macrophage Infiltration in an Animal Model of Cardiac Hypertrophy

  2020cites this paper
• p300 in Cardiac Development and Accelerated Cardiac Aging

  2020cites this paper
• Epigenetic control of natriuretic peptides: implications for health and disease

  2020cites this paper
• The Impact of Epigenetics on Cardiovascular Disease.

  2020cites this paper
• [The Therapeutic Potency of Natural Products against Heart Failure].

  2020cites this paper
• THE ROLE OF THE EPIGENOME IN HEART FAILURE.

  2020cites this paper
• The Synthetic Curcumin Analogue GO-Y030 Effectively Suppresses the Development of Pressure Overload-induced Heart Failure in Mice

  2020cites this paper
• Epigenetic control of natriuretic peptides: implications for health and disease

  2020cites this paper
• Using Epigenetics as a Pharmacological Tool in Heart Regeneration

  2019cites this paper
• Epigenetic Biomarkers in Cardiovascular Diseases

  2019influential citation
• Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy

  2019cites this paper
• Ultrasensitive electrochemiluminescence immunosensor for the transcriptional co-activator p300 by using a graphene oxide monolayer and tetrahedral DNA-mediated signal amplification

  2019cites this paper
• RFX1 downregulation contributes to TLR4 overexpression in CD14+ monocytes via epigenetic mechanisms in coronary artery disease

  2019cites this paper
• Role of SIRT1 in Modulating Acetylation of the Sarco-Endoplasmic Reticulum Ca2+-ATPase in Heart Failure

  2019cites this paper
• Curcumin, the golden spice in treating cardiovascular diseases.

  2019cites this paper
• Structure and function of the Nppa–Nppb cluster locus during heart development and disease

  2018influential citation
• Curcumin in heart failure: A choice for complementary therapy?

  2018cites this paper
• GATA Transcription Factors and Cardiovascular Disease

  2018cites this paper
• Acetylation of GATA4 on Lysine Residue K313 Promotes Osteoblastic Cells Growth

  2018cites this paper
• Curcumin and its demethoxy derivatives possess p300 HAT inhibitory activity and suppress hypertrophic responses in cardiomyocytes.

  2018cites this paper
• Epigenetics of Aberrant Cardiac Wound Healing.

  2018cites this paper
• [Noble Heart Failure Therapy Using Food Compositions].

  2018cites this paper
• Epigenomic regulation of heart failure: integrating histone marks, long noncoding RNAs, and chromatin architecture

  2018cites this paper
• Genetic and epigenetic regulation of cardiomyocytes in development, regeneration and disease

  2018cites this paper
• Progress of Genomics in Hypertension–Cardiac Hypertrophy

  2018cites this paper
• Autophagy and Epigenetics

  2018cites this paper
• New insights into epigenetic modifications in heart failure.

  2017cites this paper
• The double life of cardiac mesenchymal cells: Epimetabolic sensors and therapeutic assets for heart regeneration.

  2017cites this paper
• Curcumin and its allied analogues: epigenetic and health perspectives – a review

  2017cites this paper
• [Development of Targeted Pharmacotherapy for Cardiovascular Disease].

  2017cites this paper
• Gene activity patterns associated with pathological cardiac hypertrophy are mediated by specific chromatin modifying factors

  2017cites this paper
• A Review of the Effects of Curcumin on Histone Acetyltransferase Activity in the Prevention of Cardiac Hypertrophy

  2017cites this paper
• Epigenetic mechanisms in coronary artery disease: The current state and prospects.

  2017cites this paper
• Epigenetic regulation of cardiac fibrosis.

  2016cites this paper
• [Functional Analysis of GATA4 Complex, a Cardiac Hypertrophy-response Transcriptional Factor, Using a Proteomics Approach].

  2016cites this paper
• Unconventional Players on the Striated Muscle Field: microRNAs, Signaling Pathways and Epigenetic Regulators.

  2016cites this paper
• Physiological and pathological cardiac hypertrophy.

  2016cites this paper
• Post-translational Modification

  2016cites this paper
• The Lysine Acetyltransferases in Cardiovascular Disease

  2016cites this paper
• Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.

  2016cites this paper
• Epigenetic Regulation of Cardiac Regeneration

  2016cites this paper
• Regulation of Cardiac Transcription Factor GATA4 by Post-Translational Modification in Cardiomyocyte Hypertrophy and Heart Failure.

  2016cites this paper
• Epigenetics of the failing heart

  2015cites this paper
• Epigenetic regulation in cardiac fibrosis.

  2015cites this paper
• Nanocurcumin Prevents Hypoxia Induced Stress in Primary Human Ventricular Cardiomyocytes by Maintaining Mitochondrial Homeostasis

  2015cites this paper
• Pharmacological treatment of left ventricular remodeling: recent trial results

  2015cites this paper
• KLF15 and PPARα Cooperate to Regulate Cardiomyocyte Lipid Gene Expression and Oxidation

  2015cites this paper
• Clinical applications of curcumin

  2015cites this paper
• Epigenetic Regulation of Myocardial Homeostasis, Self-Regeneration and Senescence.

  2015cites this paper
• Alcohol-induced histone H3K9 hyperacetylation and cardiac hypertrophy are reversed by a histone acetylases inhibitor anacardic acid in developing murine hearts.

  2015cites this paper
• An epigenetic perspective on the failing heart and pluripotent-derived-cardiomyocytes for cell replacement therapy

  2015cites this paper
• Bnip3 Binds and Activates p300: Possible Role in Cardiac Transcription and Myocyte Morphology

  2015cites this paper
• Optimal dose-setting study of curcumin for improvement of left ventricular systolic function after myocardial infarction in rats.

  2014cites this paper
• Regulation of Acetylation of Histone Deacetylase 2 by p300/CBP-Associated Factor/Histone Deacetylase 5 in the Development of Cardiac Hypertrophy

  2014cites this paper
• The histone acetyltransferase MOF overexpression blunts cardiac hypertrophy by targeting ROS in mice.

  2014cites this paper
• Epigenetic Mechanisms in Heart Failure Pathogenesis

  2014cites this paper
• Inhibition of Cardiomyocyte Hypertrophy by Protein Arginine Methyltransferase 5*

  2014cites this paper
• Epigenetics in cardiac development, function, and disease

  2014cites this paper
• Kruppel-like Factor 15 Is a Critical Regulator of Cardiac Lipid Metabolism*

  2014cites this paper
• Epigenetic mechanisms underlying cardiac degeneration and regeneration.

  2014cites this paper
• Epigenetic regulation and heart failure

  2014cites this paper
• Decoding the complex genetic causes of heart diseases using systems biology

  2014cites this paper
• Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy

  2013cites this paper